Browsing by Author "Hushmandi, K."
Now showing items 1-3 of 3
-
AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation
Entezari, M.; Hashemi, D.; Taheriazam, A.; Zabolian, A.; Zabolian, A.; Fakhri, F.; Hashemi, M.; Hushmandi, K.; Ashrafizadeh, M.; Zarrabi, A.; Ertas, Y.N.; Mirzaei, S. (Elsevier, 2022)Diabetes mellitus (DM) is considered as a main challenge in both developing and developed countries, as lifestyle has changed and its management seems to be vital. Type I and type II diabetes are the main kinds and they ... -
Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation
Faskhoudi, M.A.; Molaei, P.; Sadrkhanloo, M.; Orouei, S.; Hashemi, M.; Bokaie, S.; Rashidi, M.; Entezari, M.; Zarrabi, A.; Hushmandi, K.; Mirzaei, S.; Gholami, M.H. (Elsevier GmbH, 2022)The c-Myc signaling is a new emerging target in cancer therapy. Activation of c-Myc signaling leads to cancer growth and invasion in vitro and in vivo. The stability of c-Myc can also mediate drug resistance and radioresistance ... -
Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?
Mirzaei, S.; Paskeh, M.D.A.; Saghari, Y.; Zarrabi, A.; Hamblin, M.R.; Entezari, M.; Hashemi, M.; Aref, A.R.; Hushmandi, K.; Kumar, A.P.; Rabiee, N.; Ashrafizadeh, M. (Elsevier B.V., 2022)Transforming growth factor-beta (TGF-β) is a member of a family of secreted cytokines with vital biological functions in cells. The abnormal expression of TGF-β signaling is a common finding in pathological conditions, ...
